Secondary hemophagocytic lymphohistiocytosis in pediatric patients: a single-center experience - Takeaways - MDSpire

Secondary hemophagocytic lymphohistiocytosis in pediatric patients: a single-center experience

  • By

  • Mayada Abu Shanap

  • Aseel Bzour

  • Iyad Sultan

  • Rawad Rihani

  • June 12, 2026

  • 0 min

Share

  • 1

    Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome often triggered by infections in children.

  • 2

    In a study of 16 children, infections were the most common trigger for secondary HLH, accounting for 56.3% of cases.

  • 3

    Clinical features at presentation included fever, cytopenias, splenomegaly, and hyperferritinemia, with 93.8% showing fever.

  • 4

    Thirteen out of sixteen patients achieved complete remission, and the overall survival rate was 87.5% in this cohort.

  • 5

    Metabolic disease and Langerhans cell histiocytosis were associated with refractory disease and mortality in pediatric HLH.

Original Source(s)

Related Content